Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $4.15 billion. The enterprise value is $2.74 billion.
Important Dates
The next confirmed earnings date is Tuesday, February 10, 2026, before market open.
| Earnings Date | Feb 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 264.37 million shares outstanding. The number of shares has decreased by -10.34% in one year.
| Current Share Class | 228.70M |
| Shares Outstanding | 264.37M |
| Shares Change (YoY) | -10.34% |
| Shares Change (QoQ) | +1.46% |
| Owned by Insiders (%) | 3.32% |
| Owned by Institutions (%) | 54.38% |
| Float | 216.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| Forward PS | 0.32 |
| PB Ratio | 4.00 |
| P/TBV Ratio | 4.05 |
| P/FCF Ratio | 5.63 |
| P/OCF Ratio | 5.39 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 3.72 |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 0.72.
| Current Ratio | 0.95 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.01 |
| Interest Coverage | -8.51 |
Financial Efficiency
Return on equity (ROE) is -22.24% and return on invested capital (ROIC) is -12.80%.
| Return on Equity (ROE) | -22.24% |
| Return on Assets (ROA) | -2.57% |
| Return on Invested Capital (ROIC) | -12.80% |
| Return on Capital Employed (ROCE) | -11.89% |
| Weighted Average Cost of Capital (WACC) | 12.86% |
| Revenue Per Employee | $4.70M |
| Profits Per Employee | -$101,703 |
| Employee Count | 2,400 |
| Asset Turnover | 2.21 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $5.45 million in taxes.
| Income Tax | 5.45M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -3.57% in the last 52 weeks. The beta is 1.90, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.90 |
| 52-Week Price Change | -3.57% |
| 50-Day Moving Average | 15.81 |
| 200-Day Moving Average | 16.33 |
| Relative Strength Index (RSI) | 45.99 |
| Average Volume (20 Days) | 7,853,391 |
Short Selling Information
The latest short interest is 25.11 million, so 9.50% of the outstanding shares have been sold short.
| Short Interest | 25.11M |
| Short Previous Month | 31.32M |
| Short % of Shares Out | 9.50% |
| Short % of Float | 11.61% |
| Short Ratio (days to cover) | 3.21 |
Income Statement
In the last 12 months, Oscar Health had revenue of $11.29 billion and -$244.09 million in losses. Loss per share was -$1.02.
| Revenue | 11.29B |
| Gross Profit | 1.82B |
| Operating Income | -210.34M |
| Pretax Income | -238.31M |
| Net Income | -244.09M |
| EBITDA | -180.10M |
| EBIT | -210.34M |
| Loss Per Share | -$1.02 |
Full Income StatementBalance Sheet
The company has $3.04 billion in cash and $742.06 million in debt, with a net cash position of $1.41 billion or $5.32 per share.
| Cash & Cash Equivalents | 3.04B |
| Total Debt | 742.06M |
| Net Cash | 1.41B |
| Net Cash Per Share | $5.32 |
| Equity (Book Value) | 1.03B |
| Book Value Per Share | 3.92 |
| Working Capital | -214.31M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $769.77 million and capital expenditures -$34.13 million, giving a free cash flow of $735.64 million.
| Operating Cash Flow | 769.77M |
| Capital Expenditures | -34.13M |
| Free Cash Flow | 735.64M |
| FCF Per Share | $2.78 |
Full Cash Flow StatementMargins
Gross margin is 16.16%, with operating and profit margins of -1.86% and -2.16%.
| Gross Margin | 16.16% |
| Operating Margin | -1.86% |
| Pretax Margin | -2.11% |
| Profit Margin | -2.16% |
| EBITDA Margin | -1.60% |
| EBIT Margin | -1.86% |
| FCF Margin | 6.52% |
Dividends & Yields
Oscar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 10.34% |
| Shareholder Yield | 10.34% |
| Earnings Yield | -5.89% |
| FCF Yield | 17.75% |
Analyst Forecast
The average price target for Oscar Health is $17.00, which is 8.42% higher than the current price. The consensus rating is "Hold".
| Price Target | $17.00 |
| Price Target Difference | 8.42% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 14.27% |
| EPS Growth Forecast (5Y) | 82.18% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
